About UslAdvertisinglMagazinelNewsletterlContact Usl Instagram

Fire-Based EMS: GlaxoSmithKline Awarded Up to $200M by U.S. to Develop New Antibiotics

05/24/2013
GlaxoSmithKline (GSK) plc and the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services (HHS), have agreed to a first of its kind collaboration that will support the development of several antibiotics to fight antibiotic resistance and bioterrorism. This public-private agreement marks the first time that HHS has taken a "portfolio approach" to funding drug development with a private sector company. This unique collaboration provides flexibility to move funding around GSK's antibacterial portfolio, rather than focusing on just one drug candidate and allow medicines to be studied for the potential treatment o...

To access this articles and others like, join the Fire Engineering Training Network today.

  Gain unlimited access to the most comprehensive database of firefighter training info in the world.

  Membership in the Fire Engineering Training Network includes:

  • Exclusive Online Access to FireEngineering.com News & Articles
  • Fire Engineering Magazine Historical Archives (Online-Only)
  • Annual Print Subscription to Fire Engineering Magazine
  • Annual Digital Subscription to Fire Engineering Magazine

Join Now

 Already a member? Scroll down to the Login form below to access this article.

LOGIN TODAY

FE Logo

Log into Fire Engineering and you'll have total access to the industry's leading online resource for finest training simulations, articles, instructional videos and much more.